Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.21.2
Equity (Tables)
9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of common stock outstanding

The following table summarizes the common stock activity for the three and nine months ended September 30, 2021 and 2020:

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2021

 

 

 

2020 (1)

 

 

 

2021

 

 

 

2020 (1)

 

 

Common stock:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, beginning of period

 

 

97,732,079

 

 

 

 

29,005,309

 

 

 

 

84,535,640

 

 

 

 

25,371,186

 

 

Issuance of common stock

 

 

2,592,236

 

 

 

 

-

 

 

 

 

15,788,675

 

 

 

 

3,634,123

 

 

Balance, end of period

 

 

100,324,315

 

 

 

 

29,005,309

 

 

 

 

100,324,315

 

 

 

 

29,005,309

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Retroactively restated for Business Combination

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

The following instruments were excluded from the calculation of diluted shares outstanding because the effect of including them would have been anti-dilutive.

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 



2021

 



2020

 

 

2021

 



2020

 

Employee stock options

 

5,518,473

 

 

 

7,072,426

 

 

 

10,642,260

 

 

 

7,072,426

 

Public Warrants

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Private Warrants

 

-

 

 

 

-

 

 

 

3,914,525

 

 

 

-

 

Restricted shares

 

3,035,676

 

 

 

-

 

 

 

3,035,676

 

 

 

-

 

Legacy Danimer options

 

-

 

 

 

1,805,555

 

 

 

125,490

 

 

 

1,805,555

 

Legacy Danimer warrants

 

-

 

 

 

506,611

 

 

 

-

 

 

 

506,611

 

Total excluded instruments

 

8,554,149

 

 

 

9,384,592

 

 

 

17,717,951

 

 

 

9,384,592